AUTOIMMUNE DISEASE
Clinical trials for AUTOIMMUNE DISEASE explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE DISEASE trials appear
Sign up with your email to follow new studies for AUTOIMMUNE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: immune drug tested in patients with both autoimmune disease and cancer
Disease control Recruiting nowThis study is for people who have both an autoimmune disorder (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with othe…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
New hope for vulnerable patients: remdesivir trial targets RSV in Immune-Weakened individuals
Disease control Recruiting nowThis study tests if the antiviral drug remdesivir can safely treat RSV (a common respiratory virus) in 60 adults whose immune systems are weakened by cancer treatments or autoimmune therapies. Participants must have a confirmed RSV infection with symptoms. The main goal is to see…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New autoimmune drug candidate GenSci136 enters first human safety trial
Disease control Recruiting nowThis early-stage study tests a single injection of GenSci136 in 48 healthy adults to see if it is safe and how the body processes it. The drug is being developed for autoimmune diseases, where the immune system attacks the body. Participants are randomly assigned to receive eithe…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy aims to calm overactive immune system in kidney disease
Disease control Recruiting nowThis study is testing whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely and effectively treat membranous nephropathy, a kidney disease where the immune system attacks the kidneys, causing protein to leak into urine. About 30 adults with persis…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
DNA testing for better drug choices: a 1200-Patient study
Knowledge-focused Recruiting nowThis study collects DNA samples from 1200 adults receiving routine care at the University of Chicago. Researchers test for genetic differences that could affect how patients respond to certain medications, including risk of side effects. The results are shared with their doctors,…
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 04:30 UTC
-
New tool helps melanoma patients with autoimmune conditions navigate treatment choices
Knowledge-focused Recruiting nowThis study is testing a new educational tool designed for people with melanoma who also have an autoimmune disease (like rheumatoid arthritis or Crohn's disease) and may receive immune checkpoint inhibitor drugs. Researchers want to see if the tool is easy to use and helpful for …
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC
-
Massive study aims to unlock secrets of chronic lung infections
Knowledge-focused Recruiting nowThis study follows 900 people with bronchiectasis (damaged and infected airways) to learn why they get repeated lung infections. Researchers will collect blood, spit, and genetic samples from patients and their family members. The goal is to find inherited or immune system proble…
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC